News Press release

SeqOne expands its commercial presence in Middle Eastern markets

Published on 19 November 2021

This post is also available in French

Genomics analysis becomes more accessible in MENA region: a new era for genetic diagnostics

Montpellier – November 16th 2021. SeqOne Genomics, a leader in the field of next generation genomics analysis, announces today a distribution partnership with Global Diagnostic Solutions Ltd (GDS) to commercialize SeqOne’s revolutionary genomics analysis software platform in Middle Eastern markets.

Under the terms of this agreement, Global Diagnostic Solutions Ltd. will be responsible for the Business Development, Technical & Logistics Support of SeqOne’s genomic analysis platform in the Middle-East North Africa (MENA) Region: Egypt, Turkey, Bahrain, the Kingdom of Saudi Arabia, Algeria, Tunisia, Morocco and Oman & UAE.

« GDS is a natural partner of choice since we share the same vision of tomorrow’s personalized medicine technologies. We believe that patients in the MENA region deserve to have access to the best innovations and services in the field of genomics analysis. SeqOne Genomics aims to improve healthcare standards with its unique platform, technical excellence and best in class customer support. SeqOne Genomics will shine up among GDS’ comprehensive portfolio, enabling hospital and private labs to have access and to easily deploy among their services a complete solution for state-of-the-art genomic tests»

Myriam Guiral – SeqOne’s Chief Commercial Officer

« In GDS, we believe that there is still a long way to go to overcome all the challenges to make genomic testing accessible to all, including supporting patients through the transition to the new era of diagnosis and treatment in the field of rare diseases and oncology. Thanks to SeqOne’s expertise and ours, we will be able to successfully overcome all the challenges and seamlessly support the client and his patients on this transition»

Dr. Mohamed Ramadan – co-founder of GDS

About SeqOne Genomics

A company focused on developing state-of-the-art genomic analysis tools for clinical applications in the field of rare and hereditary diseases and oncology.

About Global Diagnostic Solution Ltd.

About Global diagnostic solutions Ltd.: a company with the objective of representing tomorrow’s Molecular Genetics. Mapping all healthcare services present in the field of personalized medicine and bioinformatics diagnostics tools we choose the best diagnostic European leaders, we bring them through the MENA Region, we communicate their technology leading the genomic transformation.

This collaboration begins today, GDS welcomes any customer inquiries via its local offices, its website ( or by email:


Notify of
Inline Feedbacks
View all comments

Need help improving your genomic analysis process ?
We'd love to help !